Revenue Comparison
Chart: Revenue Comparison. Values in USD_BILLIONS. In Q2 2026: Gilead Sciences 7.803, Baxter International 2.96.
Gilead Sciences vs Baxter International: Revenue Comparison
Gilead Sciences (GILD) and Baxter International (BAX) are peers in Healthcare. Gilead Sciences reported revenue of $7.8B as of Q2 2026, compared with $3.0B for Baxter International. Gilead Sciences leads on revenue.
Gilead Sciences's gross margin is 79.8% versus 34.9% for Baxter International. Gilead Sciences's net margin is -134.5% versus 4.3% for Baxter International.
Latest Quarter Comparison
Table: Latest Quarter Comparison. 15 rows across Metric, Gilead Sciences, Baxter International.| Metric | Gilead Sciences | Baxter International |
|---|---|---|
| Market Cap | - | - |
| Revenue | $7.80B | $2.96B |
| Cost of Revenue | $1.58B | $1.93B |
| Gross Profit | $6.22B | $1.03B |
| Operating Income | $-10.39B | $217.00M |
| Net Income | $-10.50B | $126.00M |
| R&D Expense | $1.76B | $129.00M |
| Earnings Per Share | -$8.45 | $0.24 |
| Gross Margin | 79.8% | 34.9% |
| Operating Margin | -133.2% | 7.3% |
| Net Profit Margin | -134.5% | 4.3% |
| Free Cash Flow | $3.69B | $32.00M |
| Cumulative Free Cash Flow | $155.83B | $35.82B |
| Operating Cash Flow | $3.57B | $285.00M |
| Cash & Equivalents | $3.18B | $2.15B |